eMonarcHER: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study Evaluating Abemaciclib With Standard Adjuvant Hormone Therapy In Participants With HR+, HER-2+, High-Risk, Nodal-Involved Breast Cancer Who
COMMERCIAL CLINICAL TRIAL
Clinical trial information
- Promoter: LILLY, SAU
- Phase: III
- Execution start: 01/09/2021
- End of execution: 30/10/2031
- IP: ISABEL BLANCAS LOPEZ-BARAJAS